PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026ACS Medicinal Chemistry Letters2 citationsOpen Access

Novel Cyclopentapyrrole Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, namely, Narcolepsy and Hypersomnia

View Full Paper
RSRam W. Sabnis

Key Points

  • Orexin receptor agonists show promise in alleviating symptoms of sleep disorders like narcolepsy and hypersomnia.
  • New cyclopentapyrrole compounds are developed to target these receptor mechanisms effectively.
  • Pharmaceutical compositions of these compounds are designed for use in treating sleep disorders.
  • The findings may support further development of targeted therapies for sleep-related issues.

Abstract

Provided herein are novel cyclopentapyrrole compounds as orexin receptor agonists, pharmaceutical compositions, use of such compounds in treating sleep disorders, namely, narcolepsy and hypersomnia, and processes for preparing such compounds.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ram W. Sabnis (2026) studied this question.

synapsesocial.com/papers/69a7601ec6e9836116a2c8e3https://doi.org/10.1021/acsmedchemlett.6c00035
Ask AI
Helpful
Bookmark
Share
View Full Paper